MENU

The 29th Annual Meeting of Japanese Association of Cancer Immunology The 29th Annual Meeting of Japanese Association of Cancer Immunology

Program

Keynote Lecture (Joint session with SITC)

Giedre Krenciute
Department of Bone Marrow Transplantation & Cellular Therapy Comprehensive Cancer Center St. Jude Graduate School of Biomedical Sciences
Advancing CAR T Cell Therapy for Brain Tumors
Hiroaki Ikeda
Nagasaki University School of Medicine
Development of cancer immunotherapy that overcomes tumor heterogeneity

Special Symposium
Industry-Academia-Government collaboration and more

Yoshihiro Miyahara
Mie University Graduate School of Medicine
Koji Tamada
The Research Institute for Cell Design Medical Science, Yamaguchi University
Yamaguchi University Graduate School of Medicine, Department of Immunology
Endeavor for the research and development of next-generation CAR-T cell therapy
Ryosuke Maruyama
Pharmaceuticals and Medical Devices Agency
The Future of Cell and Gene Therapy: The PMDA Perspective
Toshiki Sudo
Otsuka Pharmaceutical Co., Ltd.
Establishment of Otsuka global satellite drug discovery organization through horizontal alliance
Takashi Futami
AN Venture Partners

Symposium

Symposium　1 (Joint session with SITC)
「Treatment of solid tumors with gene-modified immune cells」

Carl June
University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center
Challenges and opportunities for CAR T cells in solid tumors
Koichi Hirabayashi
Shinshu University School of Medicine
CAR-T therapy targeting epidermal growth factor receptor (EGFR)
Keishi Adachi
Yamaguchi University Faculty of Medicine and Health Sciences
The development of a novel chimeric antigen receptor (CAR) T-cell therapy platform targeting solid tumors
Sikun Meng
Graduate School of Medicine Faculty of Medicine, Osaka University
mRNA vaccine encoding CAR targeting FAP (Tentative)

Symposium　2 (Joint session with SITC)
「Cutting-edge technologies in spatial analysis and single cell omics analysis」

Dimitrios Sidiropoulos
Sidney Kimmel Cancer Center, Johns Hopkins
Spatial multi-omics reveal humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer.
Ayako Suzuki
Graduate School of Frontier Sciences, The University of Tokyo
Spatial omics analyses for revealing molecular mechanisms of lung cancer progression
Kouji Okamoto
Teikyo University Advanced Comprehensive Research Organization
Spatial Omics Analyses of Ovarian Cancer
Yoshiaki Abe
Institute of Medicine, University of Tsukuba
Microenvironment in lymphoma (Tentative)

Symposium　3 (Joint session with SITC)
「Antibody-based cancer therapy: Immune checkpoint inhibitors, antibody-drug conjugates and bispecific antibodies.」

Juan C. Osorio
Memorial Sloan Kettering Cancer Center
Treatment of Cancer with anti-CD47/ CD40 antibodies (Tentative)
Ryutaro Asano
Tokyo University of Agriculture and Technology
Design, analysis, and prodrugation of multispecific antibodies for cancer therapeutics
Akiko Zembutsu
Daiichi Sankyo, Inc.
Development of ADC to cancers (Tentative)
Shigehisa Kitano
Advanced Medical Development Center, CANCER INSTITUTE HOSPITAL OF JFCR
Development Status of Immune Checkpoint Inhibitors

Symposium　4
「The potential of immunotherapy for biliary tumors」

Shogo Kumagai
Division of Cancer immunology, Research Institute, National Cancer Center
Immune Microenvironment of Biliary Tract Cancers
Reona Sakemura
Mayo Clinic
Engineered T-Cell Therapy for Biliary Tract Cancers
Takashi Mizuno
Nagoya University Graduate School of Medicine
Current status of Immune checkpoint inhibitor therapy for biliary tract cance

Educational Lectures

Educational Lecture　1

Mitsuru Miyata
Miyata Institute of Technologies

Educational Lecture　2

Kouhei Tsumoto
Faculty Of Engineering, The University of Tokyo

Educational Lecture　3

Naoki Hosen
Department of Hematology and Oncology, Osaka University School of Medicine
Current status and perspectives of cell therapy and immunotherapy for hematological cancers

Educational Lecture　4

Shohei Koyama
Department of Immunogenomic Medicine, Research Institute, National Cancer Center
Tumor Immune Microenvironment: From Fundamentals to Cutting-Edge Insights

Educational Lecture　5

Shumpei Ishikawa
Graduate School of Medicine, The University of Tokyo
Extraction of Spatial Information of Tumor Tissue

Educational Lecture　6

Kenji Chamoto
Center for Cancer Immunology and Cancer Immunotherapy

Symposium organized by the Academic Committee

Chair

Shinichirou Fujii
Riken Center for Integrative Medical Sciences(IMS)
Kazuhiro Kakimi
Department of Immunotherapeutics, The Univercity of Tokyo Hospital

Presenters

Hidetaka Akita
Graduate School of Pharmaceutical Sciences & Faculty of Pharmaceutical Sciences, Tohoku University
Immune Activation and Application to RNA Vaccines Using Nanoparticles Based on Vitamin E-Scaffolded Lipids
Akiko Ogawa
Department of Modomics Medicine & Biology, Tohoku University
Decoding Cancer Immunopathology through RNA Modomics
Sayuri Yamazaki
Department of Immunology, Nagoya City University Graduate School of Medical Sciences
Immune regulation by dendritic cell - regulatory T cell crosstalk and tumor microenvironment
Rui Yamaguchi
Division of Cancer Systems Biology, Aichi Cancer Center Research Institute
Development of a machine learning model for predicting protein binding affinities toward immune receptor protein design

All presentation slides will be prepared in English.
Invited foreign speakers will give their presentation in English while others will mainly do so in Japanese.
However, we will provide real-time Zoom translated captions into English from other languages.